Evaluation of C-reactive protein and total serum cholesterol in adult patients with bipolar disorder

International Journal of Immunopathology and Pharmacology

Volumn 21, Issue 2, 2008, Pages 319-324

  De Berardis, Domenico ^a,b   Conti, C M ^a   Campanella, D ^a,b   Carano, A ^a,c   Scali, M ^c   Valchera, A ^d   Serroni, N ^b   Pizzorno, A M ^b   D'Albenzio, A ^a   Fulcheri, M ^a   Gambi, F ^a   La Rovere, R ^a   Cotellessa, C ^a   Salerno, R M ^a   Ferro, F M ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b ASL Teramo   (Italy)

^c ASUR Marche 8 ^*  (Italy)

^d Casa di Cura San Giuseppe   (Italy)

Author keywords

Bipolar disorder; C reactive protein; Control subjects; Depression; Euthymia; Mania; Total cholesterol

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL;

ADULT; ARTICLE; BECH RAFAELSEN MANIC RATING SCALE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; CHOLESTEROL BLOOD LEVEL; EVALUATION; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RATING SCALE; REMISSION; YOUNG MANIA RATING SCALE;

EID: 47249162405     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200802100208     Document Type: Article

References (28)

1. Baldassano CF. Illness course, comorbidity, gender, and suicidality in patients with bipolar disorder. J Clin Psychiatry 2006; 67:8-12.
2. De Berardis D, Campanella D, Gambi F et al. The role of C-reactive protein in mood disorders. Int J Immunopathol Pharmacol 2006; 19:721-27.
3. Di Giannantonio M, Frydas S, Kempuraj D et al. Cytokines in stress. Int J Immunopathol Pharmacol 2005; 18:1-9.
4. Theoharides TC, Weinkauf C, Conti P. Brain cytokines and neuropsychiatric disorders. J Clin Psychopharmacol 2004; 24:577-83.
5. Gambi F, De Berardis D, Campanella D et al. Retrospective study of C-Reactive protein, cholesterol and high density lipoprotein in major depression: preliminary findings. Eur J Inflamm 2005; 3:127-34.
6. Hornig M, Goodman DB, Kamoun M, Amsterdam JD. Positive and negative acute phase proteins in affective subtypes. J Affect Disord 1998; 49:9-14.
7. Wadee AA, Kuschke RH, Wood LA, Berk M, Ichim L, Maes M. Serological observations in patients suffering from acute manic episodes. Hum Psychopharmacol 2002; 17:175-81.
8. Swartz CM. Mania and lower serum cholesterol levels. J Clin Psychopharmacol 1995; 15:295-99.
9. Ghaemi SN, Shields GS, Hegarty JD, Goodwin FK. Cholesterol levels in mood disorders: high or low? Bipolar Disord 2000; 2:60-65.
10. Atmaca M, Kuloglu M, Tezcan E, Ustundag B, Bayik Y. Serum leptin and cholesterol levels in patients with bipolar disorder. Neuropsychobiology 2002; 46:176-81.
11. Spitzer RL, Williams JBW, Gibbon M, First M. In Structured Interview for DSM-IV (SCID), ed. New York State Psychiatric Institute Biometrics Research New York, 1997; p.1.
12. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133:429-33.
13. Bech P, Bolwig TG, Kramp P, Rafaelsen OJ. The Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale: evaluation of homogeneity and inter-observer reliability. Acta Psychiatr Scand 1979; 59:420-27.
14. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-61.
15. Ledue TB, Weiner DL, Sipe JD, Poulin SE, Collins MF, Rifai N. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid Aand mannose-binding protein in human serum. Ann Clin Biochem 1998; 35:745-50.
16. Pfrieger FW. Role of cholesterol in synapse formation and function. Biochim Biophys Acta 2003; 10:271-75.
17. Pugliese L, Bernardini I, Viola-Magni MP, Albi E. Low levels of serum cholesterol/phospholipids are associated with the antiphospholipid antibodies in monoclonal gammopathy. Int J Immunopathol Pharmacol 2006; 19:331-37.
18. Trubiani O, Guarnieri S, Orciani M, Salvolini E, Di Primio R. Sphingolipid microdomains mediate CD38 internalization: topography of the endocytosis. Int J Immunopathol Pharmacol 2004; 17:293-98.
19. Beasley CL, Honer WG, Bergmann K, Falkai P, Lutjohann D, Bayer TA. Reductions in cholesterol and synaptic markers in association cortex in mood disorders. Bipolar Disord 2005; 7:449-54.
20. Kushner I, Rzewnicki D, Samols D. What does minor elevation of C-reactive protein signify? Am J Med 2006; 119:166-71.
21. Geffken DF, Cushman M, Burke GL, Polak JF, Sakkinen PA., Tracy RP. Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol 2001; 153:242-48.
22. Huang M, Berry J, Kandere K, Lytinas M, Karalis K, Theoharides TC. Mast cell deficient W/W(v) mice lack stress-induced increase in serum IL-6 levels, as well as in peripheral CRH and vascular permeability, a model of rheumatoid arthritis. Int J Immunopathol Pharmacol 2002; 15:249-54.
23. Banks RE, Forbes MA, Storr M, Higginson J, Thompson D, Raynes J, Illingworth JM, Perren TJ, Selby PJ, Whicher JT. The acute phase protein response in patients receiving subcutaneous IL-6. Clin Exp Immunol 1995; 102:217-21.
24. Licastro F, Chiappelli M, Ruscica M, Carnelli V, Corsi MM. Altered cytokine and acute phase response protein levels in the blood of children with Down's syndrome: relationship with dementia of Alzheimer's type. Int J Immunopathol Pharmacol 2005; 18:165-69.
25. Lehtimaki T, Ojala P, Rontu R, Goebeler S, Karhunen PJ, Jylha M, Mattila K, Metso S, Jokela H, Nikkila M, Wuolijoki E, Hervonen A, Hurme M. Interleukin-6 modulates plasma cholesterol and C-reactive protein concentrations in nonagenarians. J Am Geriatr Soc 2005; 53:1552-6.
26. Motivala SJ, Sarfatti A, Olmos L, Irwin MR. Inflammatory markers and sleep disturbance in major depression. Psychosom Med 2005; 67:187-91.
27. Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J Psychiatr Res 1999; 29:141-7.
28. Dursun SM, Reveley MA. Low serum cholesterol and serotonin receptor subtypes. Br J Psychiatry 1993; 163:417-21.